Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1700 of 2026 entries
View as:

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

Phase: N/A Priority: Normal
NCT ID: NCT00683930 Org: User:
Start: 05/31/04 End: 10/31/08 Due: 10/31/09

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Phase: N/A Priority: Normal
NCT ID: NCT01063062 Org: User:
Start: 02/28/10 End: 01/17/11 Due: 01/17/12

Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1

Phase: N/A Priority: Normal
NCT ID: NCT02461290 Org: User:
Start: 04/30/08 End: 11/30/13 Due: 11/30/14

A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT01331837 Org: User:
Start: 08/02/11 End: 03/25/16 Due: 03/25/17

A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status

Phase: N/A Priority: Normal
NCT ID: NCT01271010 Org: User:
Start: 06/17/11 End: 05/04/16 Due: 05/04/17

A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT00400361 Org: User:
Start: 04/30/06 End: 04/30/11 Due: 04/30/12

(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT00354341 Org: User:
Start: 09/30/02 End: 07/31/05 Due: 07/31/06

A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04594707 Org: User:
Start: 08/30/21 End: 02/10/23 Due: 02/10/24

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Phase: N/A Priority: Normal
NCT ID: NCT03443973 Org: User:
Start: 08/22/18 End: 11/28/22 Due: 11/28/23

A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.

Phase: N/A Priority: Normal
NCT ID: NCT01195272 Org: User:
Start: 08/31/10 End: 03/31/12 Due: 03/31/13

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

Phase: N/A Priority: Normal
NCT ID: NCT01565122 Org: User:
Start: 03/31/12 End: 05/31/14 Due: 05/31/15

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

Phase: N/A Priority: Normal
NCT ID: NCT00545207 Org: User:
Start: - End: 09/30/10 Due: 09/30/11

A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01260194 Org: User:
Start: 06/30/11 End: 01/31/15 Due: 01/31/16

An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01661153 Org: User:
Start: 03/02/11 End: 09/14/16 Due: 09/14/17

A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants

Phase: N/A Priority: Normal
NCT ID: NCT01941940 Org: User:
Start: 09/05/13 End: 07/05/16 Due: 07/05/17

A Study of RO5285119 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01418963 Org: User:
Start: 07/31/11 End: 07/31/12 Due: 07/31/13

A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03001219 Org: User:
Start: 12/22/16 End: 11/06/18 Due: 11/06/19

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT05949580 Org: User:
Start: 10/21/24 End: 04/30/26 Due: 04/30/27

A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane

Phase: N/A Priority: Normal
NCT ID: NCT02658734 Org: User:
Start: 11/01/16 End: 12/14/19 Due: 12/14/20

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01343901 Org: User:
Start: 09/30/10 End: 06/30/15 Due: 06/30/16

An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection

Phase: N/A Priority: Normal
NCT ID: NCT01671046 Org: User:
Start: 07/31/12 End: 12/31/15 Due: 12/31/16

A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin

Phase: N/A Priority: Normal
NCT ID: NCT01077739 Org: User:
Start: 07/31/09 End: 01/31/12 Due: 01/31/13

Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis

Phase: N/A Priority: Normal
NCT ID: NCT06975436 Org: User:
Start: 12/30/24 End: 06/30/25 Due: 06/30/26

Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00002256 Org: User:
Start: - End: - Due: -

A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)

Phase: N/A Priority: Normal
NCT ID: NCT06128564 Org: User:
Start: 11/29/23 End: 05/30/33 Due: 05/30/34